Vall d’Hebron University Hospital’s Biobank Launches a Biological Sample Search Engine

Date: 23 April 2024
Source: www.biobanking.com

Vall d’Hebron University Hospital’s Biobank Launches a Biological Sample Search Engine

Vall d’Hebron University Hospital’s Biobank Launches a Biological Sample Search Engine

The search engine collects 65,609 cases that have been cataloged using the international classification of diseases.

Key Points:

  • Vall d’Hebron University Hospital’s Biobank unveils the first human sample search engine for research with over 65,000 cases classified by disease type.
  • The catalog features a notable collection of 3,157 rare disease cases, enhancing the visibility and accessibility of research samples.
  • The Biobank aims to contribute to the Carlos III Health Institute’s Biobanks and Biomodels Platform and the European Research Infrastructure for Biobanking.

The Biobank of Vall d’Hebron University Hospital (HUVH) has launched a pioneering human sample search engine designed to support medical research. This new tool catalogs 65,609 cases, sorted by the International Classification of Diseases and ORPHA codes for rare diseases. It includes diverse categories such as infectious, oncological, renal, cardiovascular, and respiratory diseases, with a significant emphasis on rare diseases and 3,016 COVID-19 cases.

Isabel Novoa, the director of the HUVH Biobank, stated that the initiative aims to make sample searching more accessible and transparent. This advancement is part of a broader effort by the biobank to improve data interoperability in the health sector, with future plans to integrate the OMOP common health data model in collaboration with Vall d’Hebron Information Systems.

Moreover, the Biobank is preparing to enhance its role within the European Research Infrastructure for Biobanking (BBMRI) by joining as a full member through the Biobanks and Biomodels Platform of the Carlos III Health Institute (PISCIIIBB). This move will position the HUVH Biobank to significantly contribute to advancing biomedical research across Europe.